Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 10 results:
Συντάκτης Τίτλος [ Τύπος] Έτος Φίλτρα: Συντάκτης is Syrigos, Konstantinos N [Clear All Filters]
Carboplatin plus pemetrexed as first-line treatment of patients with malignant pleural mesothelioma: a phase II study..
Clin Lung Cancer. 11(1), 30-5.
(2010). Docetaxel and intermittent erlotinib in patients with metastatic Non-Small Cell Lung Cancer; a phase II study from the Hellenic Cooperative Oncology Group..
Anticancer Res. 34(10), 5649-55.
(2014). Endoscopic and endobronchial ultrasound-guided needle aspiration in the mediastinal staging of non-small cell lung cancer..
Anticancer Res. 33(6), 2369-76.
(2013). Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS)..
BMC Cancer. 12, 342.
(2012). Genotyping and Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment..
Cancer Genomics Proteomics. 16(6), 531-541.
(2019). Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised trial..
PLoS One. 10(5), e0124612.
(2015). Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping..
Med Oncol. 35(7), 101.
(2018). Soluble E-cadherin as a diagnostic and prognostic marker in gastric carcinoma..
Folia Med (Plovdiv). 55(3-4), 26-32.
(2013). STAT-Related Profiles Are Associated with Patient Response to Targeted Treatments in Locally Advanced SCCHN..
Transl Oncol. 4(1), 47-58.
(2011).
(2012).